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Abstract The role of a Rho-associated coiled-coil forming
kinase in migration of neutrophils has been investigated. Rho-
associated coiled-coil forming kinase I was expressed in human
neutrophils. Chemotactic peptide led to a Rho-associated coiled-
coil forming kinase-dependent increase in phosphorylation of
myosin light chain. This was determined with the help of an
antibody directed against serine 19-phosphorylated myosin light
chain and an inhibitor of Rho-associated coiled-coil forming
kinase (Y-27632). Y-27632 suppressed myosin light chain
phosphorylation and chemotactic peptide-induced development
of cell polarity and locomotion with similar potency (ED50 0.5^
1.1 WM). The data strongly suggest that a Rho-associated coiled-
coil forming kinase isoform, activated in human neutrophils
exposed to chemotactic peptide, is important for motile functions
of these cells.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
In order to e⁄ciently reach sites of infection and destroy
invading bacteria, neutrophils are capable of rapid directed
movement along a chemotactic gradient. This directed move-
ment is dependent on a functional cytoskeleton [1]. Directed
cell locomotion requires, in addition to a dynamic actin net-
work, development of a polarized shape and reversible con-
tacts with the substratum. How these events are regulated is
still poorly understood. Investigations have been hampered by
the fact that neutrophils, as terminally di¡erentiated cells, are
not amenable to genetic manipulations.
Recent studies have revealed a complex network of signal-
ling systems in neutrophils [2]. The available evidence suggests
an important role of the small GTP-binding protein Rho in
neutrophil migration and adhesion. Exoenzyme C3, intro-
duced by electroporation into bovine neutrophils, inactivates
Rho selectively and suppresses cell migration [3]. It could also
be shown that Rho is crucial for integrin-mediated adhesion
of neutrophils to ¢brinogen using the same technique [4].
However the targets of Rho mediating these e¡ects have not
yet been de¢ned. The Rho-associated coiled-coil forming kin-
ases (ROCKs) ROCK I (= p160ROCK) and ROCK II, closely
related isoforms, are known to be activated by association
with GTP-Rho [5]. These enzymes have been shown to be
involved in formation of focal contacts and stress ¢bers in
several cell types, acting possibly by a¡ecting myosin light
chain (MLC) phosphorylation [5] or by phosphorylating ez-
rin/radixin/moesin proteins [6]. A recently developed com-
pound, Y-27632, suppresses ROCK I and II activity in vitro
with a Ki of 0.14^1.0 WM. Other enzymes, such as protein
kinase C, the cAMP-dependent kinase or MLC-kinase, are
inhibited at 50^s 1700-fold higher concentrations. Y-27632
is cell permeable and inhibits Rho-induced formation of focal
adhesions and stress ¢bers in HeLa-cells [7]. I now present
new data on the presence of ROCK I in human neutrophils,
on its role in MLC phosphorylation and in modulating neu-
trophil migration.
2. Materials and methods
2.1. Reagents and antibodies
fNLPNTL was from Bachem, Bubendorf, Switzerland, HSA was
from Behringwerke, Marburg, Germany, Pefabloc was from Boeh-
ringer Mannheim, Rotkreuz, Switzerland and protease inhibitor cock-
tail for mammalian cell extracts was from Sigma. Y-27632 was kindly
provided by Yoshitomi Research Laboratories, Japan. Stock solutions
of Y-27632 (10 mM) were prepared in H2O and aliquots were stored
at 320‡C. A polyclonal antibody raised in rabbits against amino acids
2^15 of p160 ROCK (antiserum 20490 [8]) was kindly provided by Dr.
T. Ishizaki. A polyclonal antibody raised in rabbits against MLC
phosphorylated on serine 19 (antiserum pp2b [9]) was a kind gift
from Dr. F. Matsumura.
2.2. Isolation of human neutrophils
Neutrophils were isolated from heparinized human blood as de-
tailed in [10]. Isolated neutrophils were resuspended in a medium
containing 138 mM NaCl, 6 mM KCl, 1 mM Na2HPO4, 5 mM
NaHCO3, 5.5 mM glucose, 20 mM HEPES, pH 7.3. Divalent cations
and HSA were added for locomotion assays (see below). Approxi-
mately 95% of the leukocytes were neutrophils, with 0.2^0.4 platelets
per neutrophil.
2.3. Immunodetection of ROCK I and of serine-19 phosphorylated
MLC
For detection of ROCK I, neutrophils were treated with diisopro-
pyl£uorophosphate in order to block endogenous proteases, followed
by solubilization of cells in 2% SDS, 10 mM Tris-Cl, pH 7.4, 10 mM
EDTA, 4 mM Pefabloc, 25 Wl protease inhibitor cocktail/ml, and
protein determination of cell lysates as described [11]. Lysates were
applied to SDS polyacrylamide gradient gels and transblotted to ni-
trocellulose [11]. Blots were exposed to a polyclonal anti-ROCK I
antibody (diluted 1:500). For visualization of bound antibody, a
goat anti-rabbit IgG antibody, conjugated to horseradish peroxidase
(Bio-Rad), diluted 1:10 000 was used, followed by ECL detection. As
a positive control for ROCK I immunoreactivity, human platelets
were isolated as described [11], solubilized in the same bu¡er as neu-
trophils (see above) and subjected to immunoblotting.
For assays of the e¡ect of cell stimulation on MLC phosphoryla-
tion, neutrophils (5U106 cells/ml) were exposed to stimuli and inhib-
itor, as indicated in Section 3. They were then centrifuged at 380Ug
to terminate the reaction, solubilized immediately in a bu¡er contain-
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ing 1% SDS, 50 mM DTT, 15% (v/v) glycerol, 62.5 mM Tris, pH 6.8,
0.001% bromophenol blue and subjected to immunoblotting using a
polyclonal antibody directed against the serine-19 phosphorylated
MLC, diluted 1:500.
2.4. Analysis of shape changes and localization of F-actin
Neutrophils (3^6U106 cells/ml) were incubated in medium in a
reciprocating waterbath at 37‡C without or with Y-27632 and
fNLPNTL, as indicated in Section 3. The reaction was stopped by
¢xing the cells in 1% glutaraldehyde (¢nal concentration) for 30 min.
Cell shape was determined as described [12]. The concentration-de-
pendent e¡ects of Y-27632 were not a¡ected by the cell density in the
range of 3^6U106 cells/ml. For visualization of F-actin, cells were
¢xed with paraformaldehyde and stained with rhodamine-phalloidin
as described [10].
2.5. Cell locomotion
For locomotion assays, a discontinuous Ficoll-metrizoate gradient
instead of neutrophil isolation medium was used for removal of
mononuclear cells [10]. Neutrophils (3U106/ml) were incubated in
medium containing in addition 1.1 mM CaCl2, 1 mM MgCl2, 100
WM EGTA, 3% HSA and inhibitor and/or stimulus at 37‡C in a
reciprocating waterbath. The cells were centrifuged at 300Ug for 5
min and resuspended in the same medium. Subsequently, the % of
migrating cells and the mean speed of migration was determined as
described [10].
2.6. Statistical analysis of data
The data correspond to mean þ S.E.M. of n independent experi-
ments. Di¡erences between the data were analyzed with the Student’s
t-test for paired data, with a P value of 6 0.05 considered signi¢cant.
3. Results
3.1. ROCK I is present in human neutrophils
A polyclonal antibody selective for ROCK I [8] reacted
with a major band of 158 kDa in human neutrophil lysates,
comigrating with a band in human platelets (Fig. 1). Human
platelets have previously been shown to contain ROCK I [8],
and cloning and sequencing of ROCK I has revealed a calcu-
lated molecular mass of 158 166 Da [13]. Quantitative evalua-
tion of the immunoblots by scanning shows, that neutrophils
contain approximately eight-fold less ROCK I, relative to the
total amount of protein, than platelets. ROCK I detected in
neutrophil lysates was not due to contamination of the prep-
aration with platelets, as a transblot of the corresponding
amount (1 Wg) of platelet protein present in 150 Wg neutrophil
protein for the preparation shown in Fig. 1 did not exhibit a
detectable ROCK I band (data not shown).
3.2. A ROCK-selective inhibitor suppresses chemotactic
peptide-induced increases in phosphorylation of MLC
on serine-19
As shown previously, ROCK isoenzymes stimulate incorpo-
ration of phosphate into the regulatory MLC II, by inhibiting
myosin phosphatase [14] and by directly phosphorylating ser-
ine-19 of MLC [15]. In order to study MLC phosphorylation,
an antibody speci¢cally reacting with a phosphopeptide cor-
responding to serine-19-phosphorylated MLC [10] has been
used. This antibody allows a selective assessment of MLC
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Fig. 1. Immunodetection of ROCK I in human neutrophils and pla-
telets. Total platelet proteins (50 Wg, lane 1) and total neutrophil
proteins (150 Wg, lane 2) were subjected to electrophoresis through a
5^10% gradient gel, followed by transfer to nitrocellulose and im-
munodetection of ROCK I. The polyclonal antibody reacts with a
major band of 158 000 Da in both platelets and neutrophils (arrow).
Numbers at the left indicate molecular masses of standard proteins
in kDa.
Fig. 2. The ROCK inhibitor Y-27632 suppresses basal and chemo-
tactic peptide-induced increases in phosphorylation of MLC at ser-
ine-19 in neutrophils. A: Cells were preincubated in medium with
or without 1 WM (1) or 10 WM (10) Y-27632 at 37‡C for 1 h, fol-
lowed by addition of medium (3) or 1 nM fNLPNTL (+), as indi-
cated, and a further incubation for 30 min. Cell lysates were then
analyzed by immunoblotting using an antibody speci¢c for MLC
phosphorylated on serine-19. The arrow indicates the main band re-
acting with the antibody against MLC phosphorylated on serine-19.
B: Quantitative evaluation of the e¡ects of Y-27632 on MLC phos-
phorylation in resting and stimulated cells. Cells were pretreated
without or with increasing amounts of Y-27632, as described for A,
followed by the addition of medium (control) or 1 nM fNLPNTL,
and a further incubation for 30 min. Cells were then analyzed by
immunoblotting and scanning of the MLC band. Mean þ S.E.M. of
3^6 experiments.
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phosphorylation mediated by ROCK I and MLC-kinase. It
reacted in neutrophil lysates with a main band of approxi-
mately 20 kDa. As shown in Fig. 2A, some background phos-
phorylation of MLC was already detectable in resting cells.
Treatment of neutrophils with 1 nM fNLPNTL for 30 min
resulted in a 2.4 þ 0.4-fold (n = 6, P6 0.0005) increase in ser-
ine-19-phosphorylated MLC (Fig. 2A,B). Pretreatment of
neutrophils with 10 WM Y-27632, an inhibitor with selectivity
for ROCK [7], prior to addition of chemotactic peptide re-
sulted in almost complete suppression of MLC phosphoryla-
tion on serine-19 (80 þ 7% inhibition, n = 4, Fig. 2A,B). Phos-
phorylation in control cells was also markedly inhibited by
68 þ 8% (n = 3, Fig. 2B). Half-maximal e¡ects on MLC phos-
phorylation in stimulated cells were obtained at approxi-
mately 0.5 WM Y-27632 (Fig. 2B).
3.3. Y-27632 suppresses chemotactic peptide induced shape
changes and locomotion in human neutrophils
As myosin has been implicated to play a crucial role in cell
migration, the e¡ect of suppressing MLC phosphorylation
with Y-27632 on shape changes, F-actin localization and mi-
gration of neutrophils was investigated. Treatment of resting
human neutrophils for 1 h with 10 WM Y27632 did not a¡ect
the smooth, spherical shape and di¡use F-actin localization as
visualized by rhodamine phalloidin, which is exhibited by 80^
90% of these cells (Fig. 3). Human neutrophils, exposed to
low (nM) concentrations of chemotactic peptide in suspension
initially form ru¥es all over the cell body. They subsequently
adopt an elongated polarized shape with a contracted tail and
a broad, F-actin-rich front lamellae (Fig. 3). Preincubation of
human neutrophils with 10 WM Y-27632 did not a¡ect the ¢rst
rapid phase of ru¥ing (data not shown) but it clearly sup-
pressed tail contraction occurring later. Cells became less
elongated and more spherical, non-polar with F-actin-rich
protrusions on one side (Fig. 3). Half-maximal suppression
of development of polarity was obtained in the range of
0.8^1.1 WM in three experiments. Development of polarity
was maximally inhibited in the range of 4^10 WM Y-27632
by 83 þ 6% (mean þ S.D., n = 3) (Fig. 4).
I investigated whether cells treated with Y-27632 and lack-
ing a contracted tail were able to migrate. The e¡ect of 10 WM
Y-27632 on fNLPNTL-stimulated locomotion of neutrophils
in the absence of a gradient (= chemokinesis) was investigated.
As shown in Table 1, the p160ROCK inhibitor indeed sup-
pressed chemokinesis to the same extent as development of
polarity (78 þ 10% inhibition by 10 WM Y-27632, n = 4). More-
over, the mean speed of the remaining locomoting cells in the
presence of 10 WM Y-27632 was signi¢cantly (P6 0.025) re-
duced compared to untreated controls (Table 1).
Interference with actin reorganization could contribute to
suppression of cell migration. Therefore the e¡ect of Y-27632
on actin reorganization in neutrophils was assessed. However,
preincubation of neutrophils with 10 WM Y-27632 did not
prevent increases in cytoskeletal actin induced by incubation
with 1 nM fNLPNTL for 1 or 30 min, determined as de-
scribed [10]. In agreement with these results, neutrophils
treated with Y-27632 prior to addition of the stimulus still
formed F-actin-rich ru¥es (Fig. 3).
FEBS 21570 19-2-99
Table 1
Y-27632 suppresses locomotion of human neutrophils
Addition Migrating cells (%) Speed of migration (Wm/min)
Medium 0 þ 0 ^
fNLPNTL (1 nM) 49 þ 6 5.3 þ 0.4
Y-27632 (10 WM) and fNLPNTL (1 nM) 12 þ 5 2.4 þ 0.3
Neutrophils (3U106/ml) were preincubated for 10 min without or with 10 WM Y-27632 at 37‡C, followed by addition of medium or 1 nM
fNLPNTL and a further incubation for 30 min. Subsequently the % of migrating cells and the mean speed of migrating cells was determined
in slide coverslip preparations at 37‡C using video microscopy. Mean þ S.E.M. of four independent experiments.
Fig. 3. Y-27632 prevents fNLPNTL-induced development of polarity in human neutrophils. Cells were preincubated in medium without (3) or
with (+) 10 WM Y-27632 at 37‡C for 1 h, followed by addition of medium (3) or 1 nM fNLPNTL (+) as indicated and a further incubation
for 30 min. At the end of the incubation period, cells were ¢xed and stained with rhodamine-phalloidin to visualize F-actin. Photographs were
obtained with Nomarski optics (upper row of panels) or in £uorescent light (lower row of panels). For cells preincubated with 10 WM Y-27632
follwed by addition of fNLPNTL, two typical examples of cells are shown. Bar: 10 Wm.
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4. Discussion
The Rho family of GTP-binding proteins has been impli-
cated in signal transduction from membrane receptors to the
cytoskeleton [16] ! I now provide new data on the involvement
of a downstream target of Rho, the Rho-activated kinase
ROCK, in controlling development of polarity and migration
of human neutrophils possibly via regulating MLC phosphor-
ylation.
The isoform ROCK I is shown to be present in human
neutrophils (Fig. 1). As a measure for the activity of
ROCK, phosphorylation of MLC on serine-19 was assessed
using a speci¢c antibody. This site is phosphorylated by
MLC-kinase and ROCK, but not by protein kinase C [15].
First, our results suggest that ROCK is constitutively active in
resting cells, maintaining part of the basal level of MLC phos-
phorylation which does not result in shape changes (Figs. 2
and 3). Second, ROCK is also crucial for regulating MLC
phosphorylation in stimulated cells. Chemotactic peptide in-
duced a signi¢cant 1.5^3-fold increase in MLC phosphoryla-
tion on serine-19 in neutrophils, sustained for at least 30 min
after addition of a stimulus, in agreement with previous data
on overall MLC phosphorylation obtained by labelling of
neutrophils with [32P]orthophosphate [17]. Serine-19 phos-
phorylation was almost completely suppressed by 10 WM of
the ROCK inhibitor Y-27632 (Fig. 2). MLC-kinase is not
a¡ected by Y-27632 under our conditions, as Y-27632 inhibits
MLC-kinase with a Kis 250 WM [7]. Y-27632 suppressed
MLC phosphorylation in stimulated neutrophils with an
ED50 of approximately 0.5 WM, in good agreement with the
Ki of 0.14^1.0 WM obtained for inhibition of ROCK I puri¢ed
from COS-cells and human platelets and the ED50 of 0.7 WM
observed for inhibition of contraction of rabbit aortic strips
[7]. Third, ROCK activity appears to be required for develop-
ment of a polar shape with a contracted tail and for stimu-
lated migration. In contrast to reports on other cell types,
ROCK activity may not be crucial for the receptor-linked
actin reorganization in neutrophils.
Neutrophils can migrate on certain substrates such as albu-
min-coated glass in the absence of a marked increase in intra-
cellular Ca2 [18]. In this context, it is of interest that in
smooth muscle cells ROCK mediates contraction in the ab-
sence of increased Ca2. In permeabilized artery preparations
for example, contraction can be induced either by addition of
1 WM free Ca2 or GTPQS, but only the latter event can be
suppressed by Y-27632 [7]. Likewise, ROCK could contribute
to migration of neutrophils in the absence of increases in
cytosolic Ca2.
In summary, evidence is provided for an important role of
ROCK in controlling the tail contraction and locomotion of
human neutrophils, possibly by regulating MLC phosphory-
lation. Other, as yet unidenti¢ed ROCK substrates, may also
be involved in modulating the neutrophil migration down-
stream of ROCK. Future studies will focus on identifying
such targets of ROCK in human neutrophils. Interesting can-
didates are for example proteins of the ezrin/moesin/radixin
family [6], putative actin-membrane linkers.
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Fig. 4. Quantitative evaluation of the e¡ect of Y-27632 on develop-
ment of cell polarity. Cells were preincubated in the presence of in-
creasing concentrations of Y-27632 for 1 h at 37‡C, followed by the
addition of 1 nM fNLPNTL and a further incubation for 30 min.
Mean þ S.D. of three independent experiments (except for 0.5 WM:
n = 2). (b) non-polar cells with surface projections; (R) polarized
cells with contracted tail.
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